Skip Nav Destination
Rise of the Clones: Myelodysplastic Syndrome to Secondary Acute Myeloid Leukemia
Kyle A. Romine; Peter van Galen
Perspectives on the Risk-Stratified Treatment of Multiple Myeloma
Faith E. Davies, et al.
Trending - Altmetric
Genomic Characterization of HIV-Associated Plasmablastic Lymphoma Identifies Pervasive Mutations in the JAK–STAT Pathway
Last mentioned on Friday July 1 2022
Targeting the EIF2AK1 signaling pathway rescues red blood cell production in SF3B1-mutant myelodysplastic syndromes with ringed sideroblasts
Last mentioned on Tuesday August 16 2022
Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape–Driven Relapse in Multiple Myeloma
Last mentioned on Wednesday August 17 2022
Disease- and Therapy-Specific Impact on Humoral Immune Responses to COVID-19 Vaccination in Hematologic Malignancies
Last mentioned on Wednesday August 17 2022
COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers
Last mentioned on Tuesday August 16 2022
